Literature DB >> 11755424

Use of mixed infections with Salmonella strains to study virulence genes and their interactions in vivo.

C R Beuzón1, D W Holden.   

Abstract

In the Salmonella-mouse model of systemic infection, high dose inoculation results in the multiplication of many of the cells present in the inoculum, rather than the clonal amplification of a small number. This characteristic has allowed the development of methods to screen multiple strains for either virulence attenuation or gene expression within the same animal. Mixed infections with mutant and wild-type strains are used to provide a sensitive measure of virulence attenuation referred to as the competitive index. We have recently used a variation of this method, involving mixed infections of single and double mutant strains, to study virulence gene interaction in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11755424     DOI: 10.1016/s1286-4579(01)01496-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  122 in total

1.  Overexpression of the recA gene decreases oral but not intraperitoneal fitness of Salmonella enterica.

Authors:  Laura Medina-Ruiz; Susana Campoy; Cristina Latasa; Paula Cardenas; Juan Carlos Alonso; Jordi Barbé
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Regulation of phenotypic heterogeneity permits Salmonella evasion of the host caspase-1 inflammatory response.

Authors:  Mary K Stewart; Lisa A Cummings; Matthew L Johnson; Alex B Berezow; Brad T Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 3.  Unraveling the secret lives of bacteria: use of in vivo expression technology and differential fluorescence induction promoter traps as tools for exploring niche-specific gene expression.

Authors:  Hans Rediers; Paul B Rainey; Jos Vanderleyden; René De Mot
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

4.  Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.

Authors:  M Chelsea Lane; Virginia Lockatell; Greta Monterosso; Daniel Lamphier; Julia Weinert; J Richard Hebel; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  The Salmonella effector protein PipB2 is a linker for kinesin-1.

Authors:  Thomas Henry; Carole Couillault; Patrick Rockenfeller; Emmanuel Boucrot; Audrey Dumont; Nina Schroeder; Aurélie Hermant; Leigh A Knodler; Patrick Lecine; Olivia Steele-Mortimer; Jean-Paul Borg; Jean-Pierre Gorvel; Stéphane Méresse
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-25       Impact factor: 11.205

6.  The Rcs phosphorelay system is specific to enteric pathogens/commensals and activates ydeI, a gene important for persistent Salmonella infection of mice.

Authors:  Kimberly D Erickson; Corrella S Detweiler
Journal:  Mol Microbiol       Date:  2006-09-29       Impact factor: 3.501

7.  Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.

Authors:  Benoit Chassaing; Estelle Garénaux; Jessica Carriere; Nathalie Rolhion; Yann Guérardel; Nicolas Barnich; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

8.  Effect of inactivation of degS on Salmonella enterica serovar typhimurium in vitro and in vivo.

Authors:  Gary Rowley; Andrew Stevenson; Jan Kormanec; Mark Roberts
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

9.  Role of neutrophils in murine salmonellosis.

Authors:  Cédric Cheminay; Dipshikha Chakravortty; Michael Hensel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection.

Authors:  Kavindra V Singh; Sreedhar R Nallapareddy; Barbara E Murray
Journal:  J Infect Dis       Date:  2007-04-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.